During the past decade, AIDS Healthcare Foundation conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AIDS Healthcare Foundation" #1 sponsor was "Gilead Sciences" with 7 trials, followed by "Glaxo Wellcome" with 7 trials sponsored, "Abbott" with 6 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored and "Community Research Initiative of New England" with 5 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AIDS Healthcare Foundation" #1 collaborator was "AIDS Healthcare Foundation" with 2 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "HIV Immunotherapeutics Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "AIDS Healthcare Foundation" are "HIV Infections" (37 trials), "HIV" (5 trials), "HIV-1 Infection" (3 trials), "HIV-1-infection" (2 trials) and "AIDS/HIV PROBLEM" (1 trials). Many other conditions were trialed in "AIDS Healthcare Foundation" in a lesser frequency.

Most popular intervention types in "AIDS Healthcare Foundation" are "Drug" (42 trials), "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lamivudine" (12 trials), "Stavudine" (12 trials), "Nelfinavir mesylate" (9 trials), "Indinavir sulfate" (7 trials) and "Zidovudine" (7 trials). Other intervention names were less common.

The vast majority of trials in "AIDS Healthcare Foundation" are 48 trials for "All" genders.

Currently, there are NaN active trials in "AIDS Healthcare Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in AIDS Healthcare Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AIDS Healthcare Foundation, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".